Streetbeat News

Revenues

AAWH

CURLF

HITI

PLNH

TCNNF

Cannabis companies are expanding their retail presence in Florida and Ohio, with Curaleaf, Planet 13, and Trulieve opening new dispensaries in Florida, and Ascend Wellness and Ethos Cannabis expanding in Ohio. High Tide celebrates a milestone with its Cabana Club loyalty program in Canada.

Portfolio Pulse from Jelena Martinovic

August 19, 2024 | 7:40 pm

SQNXF

Square Enix Holdings Co Ltd has announced the PC release date for Final Fantasy 16, set for September 17, 2024, with a price of $49.99. The release includes two DLC expansions and a Complete Edition for $69.99. A demo is available on Steam and Epic Games Store.

Portfolio Pulse from Franca Quarneti

August 19, 2024 | 7:32 pm

UMGNF

Taylor Swift's album 'The Tortured Poets Department' has seen a 600% sales increase, selling 84,000 copies last week. This surge has propelled Universal Music Group's (OTC:UMGNF) album back to the top of Billboard's Top Album Sales chart. The album's success is attributed to multiple versions with exclusive content.

Portfolio Pulse from Franca Quarneti

August 19, 2024 | 7:30 pm

MELI

MercadoLibre (NASDAQ:MELI) has significantly outperformed the market over the past 15 years, with an annualized return of 31.77%. A $1000 investment in MELI 15 years ago would now be worth $62,920.18, highlighting the power of compounded returns.

Portfolio Pulse from Benzinga Insights

August 19, 2024 | 7:30 pm

GE

GE Aero (NYSE:GE) has significantly outperformed the market over the past 5 years, with an annualized return of 33.88%. A $1000 investment in GE 5 years ago would now be worth $4,186.03, highlighting the power of compounded returns.

Portfolio Pulse from Benzinga Insights

August 19, 2024 | 7:30 pm

LMT

RTX

The U.S. has approved a potential $100 million sale of Javelin missiles to Australia, as announced by the Pentagon. This deal may involve companies like Lockheed Martin and Raytheon Technologies, which are key players in the production of these missiles.

Portfolio Pulse from Benzinga Newsdesk

August 19, 2024 | 7:07 pm

NBIX

Neurocrine Biosciences (NASDAQ:NBIX) has received varied analyst ratings over the past three months, with a general trend towards bullishness. Analysts have set a 12-month average price target of $174.87, reflecting a 5.85% increase from the previous target. The company has shown strong financial performance with a 30.37% revenue growth rate, a net margin of 11.01%, and a prudent debt management strategy.

Portfolio Pulse from Benzinga Insights

August 19, 2024 | 7:01 pm

EQH

Equitable Holdings (NYSE:EQH) has been analyzed by 9 analysts, showing a range of ratings from bullish to bearish. The average 12-month price target is $47.0, up 9.3% from the previous target. Recent analyst actions include both raises and lowers in ratings and price targets. Equitable Holdings has shown strong financial performance with significant revenue growth and high ROE, but also has a high debt-to-equity ratio.

Portfolio Pulse from Benzinga Insights

August 19, 2024 | 7:00 pm

VOYA

In the past three months, 11 analysts have provided ratings for Voya Financial (NYSE:VOYA), with a mix of bullish and indifferent sentiments. The average 12-month price target is $82.45, slightly up from the previous $81.91. Analysts have adjusted their ratings and price targets, reflecting their views on Voya's market position and financial performance. Voya Financial has shown strong financial health with a net margin of 10.1% and a return on equity of 4.9%, although its revenue growth lags behind industry peers.

Portfolio Pulse from Benzinga Insights

August 19, 2024 | 7:00 pm

FRT

Federal Realty Investment (NYSE:FRT) has been analyzed by six analysts, showing a range of perspectives from bullish to bearish. Recent analyst actions include raised price targets, with an average target of $118.5, reflecting a 7.89% increase from the previous average. The company shows strong financial metrics, including a net margin of 37.15% and a revenue growth rate of 5.48%.

Portfolio Pulse from Benzinga Insights

August 19, 2024 | 7:00 pm